Publicaciones en las que colabora con MARÍA DEL CARMEN DE JUAN CHOCANO (30)

2023

  1. Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index

    Cancers, Vol. 15, Núm. 13

  2. Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index

    PLoS ONE, Vol. 18, Núm. 10 OCTOBER

2021

  1. Obesity and telomere status in the prognosis of patients with colorectal cancer submitted to curative intention surgical treatment

    Molecular and Clinical Oncology, Vol. 15, Núm. 3

2018

  1. Función telomérica y sirtuinas 1 y 6 en cáncer colorrectal en pacientes obesos y no obesos. Correlaciones clínicas

    Anales de la Real Academia Nacional de Farmacia, Vol. 84, Núm. 1, pp. 52-71

2016

  1. Clinical relevance of telomere status and telomerase activity in colorectal cancer

    PLoS ONE, Vol. 11, Núm. 2

2015

  1. Prognostic value of telomere function in gastric cancers with and without microsatellite instability

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 2, pp. 162-169

  2. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status

    Journal of Experimental and Clinical Cancer Research, Vol. 34, Núm. 1

2014

  1. Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity

    Journal of Experimental and Clinical Cancer Research, Vol. 33, Núm. 1

2012

  1. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition

    Oncology, Vol. 82, Núm. 3, pp. 153-164

  2. Methylation profiling in non-small cell lung cancer: Clinical implications

    International Journal of Oncology, Vol. 40, Núm. 3, pp. 739-746

2011

  1. Expression of human MDGA1 increases cell motility and cell-cell adhesion and reduces adhesion to extracellular matrix proteins in MDCK cells

    Cancer Microenvironment, Vol. 4, Núm. 1, pp. 23-32

2010

  1. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway

    International Journal of Oncology, Vol. 36, Núm. 5, pp. 1209-1215

2008

  1. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability

    Clinical Cancer Research, Vol. 14, Núm. 4, pp. 995-1001

  2. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer

    Lung Cancer, Vol. 60, Núm. 3, pp. 416-425

2007

  1. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer

    Oncology Reports, Vol. 17, Núm. 1, pp. 217-223

  2. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

    Hepato-Gastroenterology, Vol. 54, Núm. 73, pp. 315-319

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

2005

  1. Characterization of MDGA1, a novel human glycosylphosphatidylinositol- anchored protein localized in lipid rafts

    Experimental Cell Research, Vol. 307, Núm. 1, pp. 91-99

  2. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

2004

  1. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

    International journal of oncology, Vol. 24, Núm. 2, pp. 349-355